<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260715070206N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-10-03</date_registration>
      <primary_sponsor>University of managment and technology</primary_sponsor>
      <public_title>Comparing NMES and Percussion Therapy for Improving Arm Movement After Stroke</public_title>
      <acronym></acronym>
      <scientific_title>Comparative Effects of Low-Frequency Neuromuscular Electrical Stimulation and Percussive Mechanical Stimulation on Upper Limb Function and Spasticity in Post-Stroke Patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-08-25</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>34</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/93010</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Simple randomization will be used. Sealed opaque envelopes containing group allocation (Group A or Group B) will be prepared, shuffled, and numbered sequentially. Each participant will pick one envelope after baseline assessment, which will be opened by an independent researcher to reveal group allocation. Allocation concealment will be ensured through opaque, sealed, and sequentially numbered envelopes. The outcome assessor will remain blinded to group allocation, Blinding description: Single-blinded. The outcome assessor will be blinded to group allocation. Participants and therapists cannot be blinded due to the nature of the interventions.</study_design>
      <phase>2</phase>
      <hc_freetext>Chronic stroke (cerebrovascular accident) is a neurological condition resulting from interruption of blood flow to the brain, which may lead to persistent impairments in motor function, balance, coordination, mobility, and activities of daily living. This study focuses on individuals with chronic stroke undergoing rehabilitation..</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Participants in the low-frequency neuromuscular electrical stimulation (NEMS) group will receive NEMS at a frequency of 5 Hz in addition to conventional physiotherapy. Stimulation will be delivered using symmetric biphasic pulses with a pulse width of 200 μs, a ramp time of 4 seconds, an ON time of 20 seconds, and an OFF time of 10 seconds. Surface electrodes will be placed over the motor points of the target extensor muscles, including the wrist extensors, finger extensors, and triceps brachii. The stimulation will be applied for approximately 5 minutes to each target muscle, with a total intervention duration of 60 minutes per session. Participants will receive three sessions per week for four weeks, for a total of 12 sessions. Conventional physiotherapy, including range-of-motion exercises, strengthening exercises, PNF patterns, and gait training, will be provided alongside the intervention. Intervention 2: Intervention group: Participants in the percussive mechanical stimulation group will receive percussive mechanical stimulation at a frequency of 50–60 Hz in addition to conventional physiotherapy. The stimulation will be applied perpendicular to the muscle belly near the distal tendon insertion of the target extensor muscles, including the wrist extensors, finger extensors, and triceps brachii. Each target muscle will receive approximately 30 seconds to 3 minutes of percussive stimulation, with a total intervention duration of 60 minutes per session. Participants will receive three sessions per week for four weeks, for a total of 12 sessions. Conventional physiotherapy, including range-of-motion exercises, strengthening exercises, PNF patterns, and gait training, will be provided alongside the intervention.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is Deidentified individual participant data will not be shared publicly due to participant privacy and confidentiality considerations.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>RIMSHA</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>House no 9, 32-F muhallah usmanpura shalimar town lahore</address>
        <city>LAHORE</city>
        <country1>Pakistan</country1>
        <zip>54000</zip>
        <telephone>+92 320 4408157</telephone>
        <email>S2025549004@umt.edu.pk</email>
        <affiliation>University of managment and technology</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Sajjad Ali</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Raiwand Road, Lahore</address>
        <city>LAHORE</city>
        <country1>Pakistan</country1>
        <zip>54000</zip>
        <telephone>+92 334 7329370</telephone>
        <email>sajjad.ali@umt.edu.pk</email>
        <affiliation>university of managment and technology, lahore</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>40 to 70 years of age.
Both male and female genders were included
Patient with UE-fugl meyer assessment score 1 to 50.
Stroke duration greater then 4 month subacute or chronic
Patient must present with upper limb brunnstrom recovery stage 2 to 5.
Confirmed Upper limb spasticity by modified tardieu scale &gt;1</inclusion_criteria>
      <agemin>40 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Implanted electronic device (pacemaker).
Fracture of upper limb.
Traumatic brain injury.
Transient ischemic attack.
Severe cognitive impairment on mini mental scale
History of Epilipsy</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I64</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Stroke, not specified as haemorrhage or infarction</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Participants in the low-frequency neuromuscular electrical stimulation (NEMS) group will receive NEMS at a frequency of 5 Hz in addition to conventional physiotherapy. Stimulation will be delivered using symmetric biphasic pulses with a pulse width of 200 μs, a ramp time of 4 seconds, an ON time of 20 seconds, and an OFF time of 10 seconds. Surface electrodes will be placed over the motor points of the target extensor muscles, including the wrist extensors, finger extensors, and triceps brachii. The stimulation will be applied for approximately 5 minutes to each target muscle, with a total intervention duration of 60 minutes per session. Participants will receive three sessions per week for four weeks, for a total of 12 sessions. Conventional physiotherapy, including range-of-motion exercises, strengthening exercises, PNF patterns, and gait training, will be provided alongside the intervention.</i_keyword>
      <i_keyword>Intervention group: Participants in the percussive mechanical stimulation group will receive percussive mechanical stimulation at a frequency of 50–60 Hz in addition to conventional physiotherapy. The stimulation will be applied perpendicular to the muscle belly near the distal tendon insertion of the target extensor muscles, including the wrist extensors, finger extensors, and triceps brachii. Each target muscle will receive approximately 30 seconds to 3 minutes of percussive stimulation, with a total intervention duration of 60 minutes per session. Participants will receive three sessions per week for four weeks, for a total of 12 sessions. Conventional physiotherapy, including range-of-motion exercises, strengthening exercises, PNF patterns, and gait training, will be provided alongside the intervention.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Upper limb function. Timepoint: Before intervention, After intervention. Method of measurement: Fugl-Meyer Assessment Upper Extremity (FMA-UE).</prim_outcome>
      <prim_outcome>Spasticity. Timepoint: before intervention, after intervention. Method of measurement: Modified Tardieu Scale (MTS).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Gross manual dexterity. Timepoint: before intervention, after intervention. Method of measurement: Box and Block test.</sec_outcome>
      <sec_outcome>Fine manual dexterity. Timepoint: before intervention, after intervention. Method of measurement: 9- Hole peg test.</sec_outcome>
      <sec_outcome>Activity of Daily Livings. Timepoint: before intervention, after intervention. Method of measurement: barthel index.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Self-funded by the investigator</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-09-25</approval_date>
        <contact_name>Research ethics and support committee of University of Management and technology, Lahore</contact_name>
        <contact_address>C-II, Johar town, Lahore Lahore Punjab Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
